Santeon-CAP; Dexamethasone in Community-acquired Pneumonia
Status:
Terminated
Trial end date:
2018-09-13
Target enrollment:
Participant gender:
Summary
The present study is designed to investigate the beneficial effects of adjunctive
dexamethasone therapy in patients admitted with community-acquired pneumonia, additionally
aiming at assessing what patients benefit from dexamethasone treatment mostly. A large
multicenter study will be conducted comparing a 4 days dexamethasone 6 mg per os course with
placebo in 600 patients and with predefined subgroup analyses planned.